Home533573 • BOM
add
Alembic Pharmaceuticals Ltd
Previous close
₹856.90
Day range
₹854.50 - ₹862.00
Year range
₹725.60 - ₹1,122.40
Market cap
167.88B INR
Avg Volume
9.74K
P/E ratio
26.45
Dividend yield
1.29%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 19.10B | 15.91% |
Operating expense | 11.55B | 9.95% |
Net income | 1.85B | 20.40% |
Net profit margin | 9.67 | 3.87% |
Earnings per share | 9.40 | 29.92% |
EBITDA | 3.15B | 31.87% |
Effective tax rate | 17.88% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.43B | 10.92% |
Total assets | 83.97B | 16.14% |
Total liabilities | 30.81B | 31.52% |
Total equity | 53.16B | — |
Shares outstanding | 196.50M | — |
Price to book | 3.17 | — |
Return on assets | — | — |
Return on capital | 9.04% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 1.85B | 20.40% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1907
Employees
16,571
